160 related articles for article (PubMed ID: 32488916)
1. How do people in prison feel about opt-out hepatitis C virus testing?
Jack K; Linsley P; Thomson BJ; Irving WL
J Viral Hepat; 2020 Oct; 27(10):1003-1011. PubMed ID: 32488916
[TBL] [Abstract][Full Text] [Related]
2. Testing for hepatitis C virus infection in UK prisons: What actually happens?
Jack K; Thomson BJ; Irving WL
J Viral Hepat; 2019 Jun; 26(6):644-654. PubMed ID: 30702194
[TBL] [Abstract][Full Text] [Related]
3. An opt-out approach to hepatitis C virus testing in English prisons: the literature underpinning the policy.
Jack K
Br J Nurs; 2021 Nov; 30(20):1158-1164. PubMed ID: 34761976
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of HCV in prisons in Wales, UK and the impact of moving to opt-out HCV testing.
Perrett SE; Plimmer A; Shankar AG; Craine N
J Public Health (Oxf); 2020 May; 42(2):423-428. PubMed ID: 32090269
[TBL] [Abstract][Full Text] [Related]
5. Prison officers' views about hepatitis C testing and treatment: a qualitative enquiry.
Jack K; Islip N; Linsley P; Thomson B; Patterson A
J Clin Nurs; 2017 Jul; 26(13-14):1861-1868. PubMed ID: 27486922
[TBL] [Abstract][Full Text] [Related]
6. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
[TBL] [Abstract][Full Text] [Related]
7. Detection, stratification and treatment of hepatitis C-positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
Connoley D; Francis-Graham S; Storer M; Ekeke N; Smith C; Macdonald D; Rosenberg W
J Viral Hepat; 2020 Oct; 27(10):987-995. PubMed ID: 32449969
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.
Crowley D; Van Hout MC; Murphy C; Kelly E; Lambert JS; Cullen W
Health Justice; 2018 Dec; 6(1):23. PubMed ID: 30569249
[TBL] [Abstract][Full Text] [Related]
9. Consensus recommendations on the management of hepatitis C in Australia's prisons.
Winter RJ; Sheehan Y; Papaluca T; Macdonald GA; Rowland J; Colman A; Stoove M; Lloyd AR; Thompson AJ
Med J Aust; 2023 Mar; 218(5):231-237. PubMed ID: 36871200
[TBL] [Abstract][Full Text] [Related]
10. Understanding how, why, for whom, and under what circumstances opt-out blood-borne virus testing programmes work to increase test engagement and uptake within prison: a rapid-realist review.
Francis-Graham S; Ekeke NA; Nelson CA; Lee TY; Haj SE; Rhodes T; Vindrola C; Colbourn T; Rosenberg W
BMC Health Serv Res; 2019 Mar; 19(1):152. PubMed ID: 30849986
[TBL] [Abstract][Full Text] [Related]
11. "That was quick, simple, and easy": Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison.
Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR
Int J Drug Policy; 2022 Jan; 99():103456. PubMed ID: 34560624
[TBL] [Abstract][Full Text] [Related]
12. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
Mohamed Z; Al-Kurdi D; Nelson M; Shimakawa Y; Selvapatt N; Lacey J; Thursz MR; Lemoine M; Brown AS
Int J Drug Policy; 2020 Jan; 75():102608. PubMed ID: 31759307
[TBL] [Abstract][Full Text] [Related]
13. Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison.
Byrne CJ; Malaguti A; Inglis SK; Dillon JF
BMJ Open; 2023 Apr; 13(4):e068604. PubMed ID: 37037621
[TBL] [Abstract][Full Text] [Related]
14. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
Morey S; Hamoodi A; Jones D; Young T; Thompson C; Dhuny J; Buchanan E; Miller C; Hewett M; Valappil M; Hunter E; McPherson S
J Viral Hepat; 2019 Jan; 26(1):101-108. PubMed ID: 30315691
[TBL] [Abstract][Full Text] [Related]
15. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
Rance J; Lafferty L; Treloar C;
Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
[TBL] [Abstract][Full Text] [Related]
16. Constructing a middle-range theory to explain the uptake of hepatitis C tests in prison.
Jack K; Linsley P
Nurse Res; 2021 Jun; 29(2):33-40. PubMed ID: 33733646
[TBL] [Abstract][Full Text] [Related]
17. 'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners.
Khaw FM; Stobbart L; Murtagh MJ
BMC Public Health; 2007 Jun; 7():98. PubMed ID: 17555573
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
[TBL] [Abstract][Full Text] [Related]
19. A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons.
Craine N; Whitaker R; Perrett S; Zou L; Hickman M; Lyons M
Eur J Public Health; 2015 Apr; 25(2):351-7. PubMed ID: 25061233
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on Integrated HIV and Hepatitis C Virus Testing Among Persons Entering a Northern California Jail: A Pilot Study.
Ly W; Cocohoba J; Chyorny A; Halpern J; Auerswald C; Myers J
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):214-220. PubMed ID: 29474267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
